Jeremy N Kay
NIH Rank #8108
- Program Leader
- R01 Holder
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8723101Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Neurosciences
NIH Funding · FY2024
Linked Award Amount
$1.6M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#8,108
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Jeremy N Kay as a PI. Multi-PI records show the full award amount for context.
- 1R01EY035637-01R01Molecular and cellular requirements for Crb1 gene function in the onset and therapeutic rescue of an inherited retinal degeneration$565.5Kaward amount
- 5R01EY031445-04R01Precise assembly of retinal circuitry through rejection of inappropriate synaptic partners$434.4Kaward amount
- 5R01EY030611-05R01Mechanisms of naturally-occurring astrocyte death during retinal development$392.2Kaward amount
- $128.6Kaward amount
- 1R13EY035915-01R132024 Visual System Development Gordon Research Conference and Gordon Research Seminar$40Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Jeremy N Kay as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDuke University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #8108
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Jeremy N Kay.